The purpose of this study is to choose the preferred treatment modality for multiple, small hepatocellular carcinomas.
To compare the below things between PEIT group and TACE group 1. Survival 1. 5 year overall survival rate 2. Disease free survival rate 2. Recurrence a. recurrence rate
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
22
lipiodol, adriamycin and/or mitomycin
99% ethanol 2-4cc per one session, two to three sessions per single procedure for one week
Seoul NUH
Seoul, Chongno-gu, South Korea
overall survival rate
Time frame: 5 year
Disease free survival rate and recurrence rate
Time frame: 5 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.